Regulatory affairs

When you are dealing with the different regulatory requirements around the globe relating to all phases of your product’s approval and marketing, you want to work with the most highly qualified, experienced and approachable team you can find. After all, you are under pressure from the regulators. You want a confident partner at your side.

Envigo’s regulatory affairs team is equipped with the knowledge and skills to provide your company with a comprehensive understanding of current regulatory guidelines and procedures. Our experienced consultancy group provides practical advice and support to our drug development customers in moving products from early concept to marketing authorization. With a proven track record of success across the world, we can help you throughout the entire lifecycle of your product to achieve your goals in a fast, low risk and efficient manner. With offices in the UK, US and Japan, we provide regulatory services throughout the ICH regions, and we can offer a global regulatory service through our affiliations in other non-ICH regions.

Expand All Tabs
  • Preparation of marketing authorization applications, clinical trial Authorization applications and INDs
  • Preparation of requests for scientific advice from FDA, EMA and EU national authorities
  • Support for customers in Regulatory Authority meetings; advice on regulatory strategy; due diligence on existing data packages
  • Preparation of orphan drug designations in EU and US, pediatric investigation plans and drug master files
  • Advice on individual study designs, taking into account product type and therapeutic class, and review and interpretation of study data
  • Regulatory support for the development of devices, drug/device combinations and borderline products.
  • Clinical trial legal representative services for non-EU companies and US Agent services for non-US companies


We work with a full range of medicinal products including new chemical entities (NCEs), biologics, advanced therapies and generics. We have experience with the following product types:

  • Small molecules
  • Protein-based therapeutics
  • DNA-based therapeutics
  • Drug delivery systems
  • Re-profiled known active pharmaceutical ingredients (APIs)
  • Generics
  • Drug-device combinations
  • Herbal medicines

We can maximize the success of your product by assisting you with:

Clinical trials (phase I, II & III):

  • Due diligence
  • Agency and working party meetings e.g ITF meeting
  • Scientific advice / protocol assistance
  • CTA / IND applications and maintenance
  • Pediatric investigation plans
  • Orphan drug designation
  • Fast track applications / special protocol assistance
    • marketing authorization applications
  • Pre submission meetings
  • MAA/NDA/BLA preparation and filing
  • eCTD and NeeS submissions
  • Drug master files
  • Responses to agency questions
    • Post marketing approval
  • License variations
  • Renewals
  • Line extensions
  • Submissions to additional countries (MRP)
  • Product maintenance

The future of inhaled medications and inhalation technology

[Webinar] De-risking drug development: in vitro strategies that add value to your molecule